2019-2023 Europe Cancer Diagnostics Market Segmentation Analysis: France, Germany, Italy, Spain, UK--Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

Publisher Name :
Date: 04-Apr-2019
No. of pages: 820

The report is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget.

This new report from LeadingMarketResearch.com is based on a study of the major business opportunities emerging in the European cancer diagnostics market during the next five years. The report examines trends in the European market; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers.

Rationale

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the European cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion.

Geographic Coverage

France, Germany, Italy, Spain, UK

European Market Overview

- Five-year test volume and sales projections by country.

- Comprehensive market segmentation analysis, including review of the market dynamics, structure, size, growth and major suppliers by country.

- Estimated universe of laboratories performing cancer diagnostic testing by country.

- Cancer statistics, etiology and recent developments in Europe.

Business Opportunities and Strategic Recommendations

- Specific new product development opportunities with potentially significant market appeal during the next five years.

- Design criteria for new products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Over 200 Current and Emerging Cancer Diagnostic Test

- Oncogenes

- Biochemical Markers

- Growth Factors

- Colony Stimulating Factors

- Hormones

- Immunohistochemical Stains

- Lymphokines

Supplier Shares, Sales and Volume Forecasts

- Sales and market shares of major cancer diagnostic product suppliers by individual test and country.

- Five-year test volume and sales forecasts for major tumor markers by country and market segment, including:

     º  Hospitals

     º  Commercial/Private Laboratories

     º  Physician Offices/Group Practices

Instrumentation Review

- Analysis of major molecular diagnostic and immunodiagnostic analyzers used for cancer testing, including their operating characteristics, features and selling prices.

Technology Assessment

- Assessment of latest technologies and their potential applications for cancer diagnostic testing.

- Review of competing/complementing technologies.

- Extensive listings of companies, universities and research centers developing new cancer diagnostic tests and detection technologies.

Competitive Strategies

- Strategic assessments of major suppliers and start-up firms developing innovative cancer diagnostic technologies and products, including their sales, product portfolios, marketing tactics, collaborative arrangements, and new products in R&D.

Contains 820 pages and 320 tables

2019-2023 Europe Cancer Diagnostics Market Segmentation Analysis: France, Germany, Italy, Spain, UK--Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

Table of Contents

I. Introduction
II. European Market Overview
A. Market Overview
B. European Market Structure
C. European Market Size and Growth
III. Major Product Development Opportunities
A. Reagent Kits and Test Systems/Panels
B. Instrumentation
C. Computers, Software and Automation
D. Auxiliary Products
IV. Design Criteria for Decentralized Testing Products
V. Alternative Market Penetration Strategies
VI. Potential Market Entry Barriers and Risks
VII. Worldwide Market and Technology Overview
A. Major Current and Emerging Cancer Diagnostic Tests
1. Biochemical Tumor Markers
2. Oncogenes
3. Polypeptide Growth Factors
4. Ectopic Hormones
5. Colony Stimulating Factors
6. Lymphokines
7. Immunohistochemical Stains
8. Emerging Tumor Markers
B. Instrumentation Review and Market Needs
C. Current and Emerging Technologies
D. Personal Testing
VIII. France
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
- Volume Forecasts by Test and Market Segment
- Sales Forecasts by Test and Market Segment
- Major Supplier Sales and Market Shares
IX. Germany
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
- Volume Forecasts by Test and Market Segment
- Sales Forecasts by Test and Market Segment
- Major Supplier Sales and Market Shares
X. Italy
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
- Volume Forecasts by Test and Market Segment
- Sales Forecasts by Test and Market Segment
- Major Supplier Sales and Market Shares
XI. Spain
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
- Volume Forecasts by Test and Market Segment
- Sales Forecasts by Test and Market Segment
- Major Supplier Sales and Market Shares
XII. U.K.
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
- Volume Forecasts by Test and Market Segment
- Sales Forecasts by Test and Market Segment
- Major Supplier Sales and Market Shares
XIII. Competitive Profiles
- Abbott
- AdnaGen
- Agilent Technologies
- Applied Gene Technologies
- Arca Biopharma
- Beckman Coulter/Danaher
- Becton Dickinson
- Biomedical Diagnostics
- bioMerieux
- Bio-Rad
- CellSearch
- Cepheid
- Correlogic Systems/Vermillion
- Decode Genetics
- Diadexus
- Diagnocure
- Diasorin
- Eiken Chemical
- Elitech Group
- Epigenomics
- Enterix
- Enzo Biochem
- Exact Sciences
- Fujirebio
- Guided Therapeutics
- Hologic/Gen-Probe
- Kreatech/Leica
- Kyowa Medex
- Mackay Life Sciences
- Myriad Genetics
- OncoLab
- Ortho-Clinical Diagnostics
- Panacea Pharmaceuticals
- Polartechnics
- Polymedco
- PreMD
- Qiagen
- Quest Diagnostics
- Radient Pharmaceuticals
- Roche
- Scienion
- Sequenom
- Siemens Healthcare
- Takara Bio
- Targeted Diagnostics & Therapeutics
- Thermo Fisher
- Tosoh
- Veridex
- Wako Pure Chemicals
- Wallac/PE
- Zila
XIV. Appendix: Major Universities and Research
Centers Developing Cancer Diagnostic
Technologies and Applications

List of Tables

Cancer Diagnostic Classification
Major Companies Developing or Marketing ACTH Tests
Major Companies Developing or Marketing AFP Tests
Major Companies Developing or Marketing Beta-2 Microglobulin Tests
Major Companies Developing or Marketing CA 15-3/27.29 Tests
Major Companies Developing or Marketing CA 19-9 Tests
Major Companies Developing or Marketing CA 125 Tests
Major Companies Developing or Marketing Calcitonin Tests
Major Companies Developing or Marketing CEA Tests
Major Companies Developing or Marketing Estrogen Receptor Tests
Major Companies Developing or Marketing Progesterone Receptor Tests
Major Companies Developing or Marketing Ferritin Tests
Major Companies Developing or Marketing Gastrin Tests
Major Companies Developing or Marketing HCG Tests
Major Companies Developing or Marketing Insulin Tests
Major Companies Developing or Marketing NSE Tests
Major Companies Developing or Marketing Occult Blood Tests
Major Companies Developing or Marketing PAP Smear/HPV Tests
Major Companies Developing or Marketing PAP Tests
Major Companies Developing or Marketing PSA Tests
Major Companies Developing or Marketing Lymphocyte Subclassification Tests
Biochemical Markers Potential Applications In Cancer Diagnosis
Oncogenes Potential Applications In Cancer Diagnosis
Major Companies Developing or Marketing Oncogene Tests
Growth Factors Potential Applications In Cancer Diagnosis
Colony Stimulating Factors Potential Applications in Cancer Diagnosis
Lymphokines Potential Applications In Cancer Diagnosis
Immunohistochemical Stains Potential Applications in Cancer Diagnosis
Executive Summary Table: France, Total Cancer Diagnostic Testing Volume and Sales Forecasts by Market Segment
France, Estimated Cancer Death Rates
France, Laboratories Performing Cancer Diagnostic Tests by Market Segment
France, Hospital Laboratories Performing Cancer Diagnostic Tests by Bed Size
France, Commercial/Private Laboratories Performing Cancer Diagnostic Test by Annual Test Volume
France, Total Cancer Diagnostic Test Volume Forecasts by Market Segment
France, All Market Segments Major Cancer Diagnostic Test Volume Forecasts by Test
France, Hospital Laboratories Major Cancer Diagnostic Test Volume Forecasts by Test
France, Commercial/Private Laboratories Marker Test Volume Forecasts
France, Total Cancer Diagnostic Sales Major Cancer Diagnostic Forecasts by Market Segment
France, All Market Segments Major Cancer Diagnostic Sales Forecasts by Test
France, Hospital Laboratories Major Cancer Diagnostic Sales Forecasts by Test
France, Commercial/Private Laboratories Cancer Diagnostic Market Forecasts by Test
France, ACTH Test Volume and Diagnostics Sales Forecasts by Market Segment
France, AFP Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecasts by Market Segment
France, CA 15-3/27.29 Test Volume and Diagnostics Sales Forecasts by Market Segment
France, CA 19-9 Test Volume and Diagnostics Sales Forecasts by Market
France, CA-125 Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Calcitonin Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Cathepsin Test Volume and Diagnostics Sales Forecasts by Market Segment
France, CEA Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Colon-Specific Antigen Test Volume And Diagnostics Sales Forecasts by Market Segment
France, Cytokeratins Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Estrogen Receptor Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Ferritin Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Gastrin Test Volume and Diagnostics Sales Forecasts by Market Segment
France, HCG Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Insulin Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Interferons Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Interleukins Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Lymphocyte Subtyping Test Volume And Diagnostics Sales Forecasts by Market Segment
France, NSE Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Nucleolar Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Occult Blood Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Oncogenes Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment
France, PAP Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Parathyroid Hormone Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Progesterone Receptor Test Volume And Diagnostics Sales Forecasts by Market Segment
France, PAP Test Volume and Diagnostics Sales Forecasts by Market Segment
France, PSA Test Volume and Diagnostics Sales Forecasts by Market Segment
France, S-100 Protein Test Volume and Sales Diagnostics Sales Forecasts by Market Segment
France, Serotonin Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Sialic Acid Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment
France, TDT Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Thymidine Kinase Test Volume And Diagnostics Sales Forecasts by Market Segment
France, Thyroglobulin Test Volume and Diagnostics Sales Forecasts by Market Segment
France, TPA Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Total Cancer Diagnostics Sales By Major Suppliers
France, AFP Testing Market Diagnostics Sales by Major Supplier
France, CA 15-3 Testing Market Diagnostics Sales by Major Supplier
France, CA 19-9 Testing Market Diagnostics Sales by Major Supplier
France, CA 125 Testing Market Diagnostics Sales by Major Supplier
France, CEA Testing Market Diagnostics Sales by Major Supplier
France, NSE Testing Market Diagnostics Sales by Major Supplier
France, PAP Testing Market Diagnostics Sales by Major Supplier
France, PSA Testing Market Diagnostics Sales by Major Supplier
Executive Summary Table: Germany, Total Cancer Diagnostic Testing Volume and Sales Forecasts By Market Segment
Germany, Estimated Cancer Death Rates
Germany, Laboratories Performing Cancer Diagnostic Tests by Market Segment
Germany, Hospital Laboratories Performing Cancer Diagnostic Tests by Bed Size
Germany, Commercial/Private Laboratories Performing Cancer Diagnostic Tests by Annual Test Volume
Germany, Total Cancer Diagnostic Test Volume Forecasts by Market Segment
Germany, All Market Segments, Major Cancer Diagnostic Test Volume Forecasts by Test
Germany, Hospital Laboratories, Major Cancer Diagnostic Test Volume Forecasts by Test
Germany, Commercial/Private Laboratories Major Cancer Diagnostic Test Volume Forecasts
Germany, Physician Offices/Group Practices Major Cancer Diagnostic Test Volume Forecasts
Germany, Total Cancer Diagnostic Sales Forecasts by Market Segment
Germany, All Market Segments Major Tumor Marker Sales Forecasts by Test
Germany, Hospital Laboratories, Major Tumor Marker Sales Forecasts by Test
Germany, Commercial/Private Laboratories Major Cancer Diagnostic Sales Forecasts by Test
Germany, Physician Offices/Group Practices Major Cancer Diagnostic Sales Forecasts by Test
Germany, ACTH Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, AFP Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, Beta-2 Microglobulin Test Volume And Diagnostics Sales Forecasts by Market Segment
Germany, CA-15-3/27.29 Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, CA-19 Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, CA 125 Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, Calcitonin Test Volume And Diagnostic Sales Forecasts by Market Segment
Germany, Cathepsin Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, CEA Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, Chromogranin Test Volume And Diagnostics Sales Forecasts by Market Segment
Germany, Colon-Specific Antigen Test Volume And Diagnostics Sales Forecasts by Market Segment
Germany, Cytokeratins Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, Estrogen Receptor Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, Ferritin Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, Gastrin Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, HCG, Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, Insulin Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, Interferons Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, Interleukins Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, NSE Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, Occult Blood Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, Oncogenes Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, Pap Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, Parathyroid Hormone Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, Progesterone Receptor Test Volume And Diagnostics Sales Forecasts by Market Segment
Germany, PAP Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, PSA Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, S-100 Protein Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, Serotonin Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, Sialic Acid Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecasts By Market Segment
Germany, TDT Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, Thymidine Kinase Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, Thyroglobulin Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, TPA Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, Total Cancer Diagnostics Sales By Major Supplier
Germany, AFP Testing Market Diagnostics Sales by Major Supplier
Germany CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
Germany CA 19-9 Testing Market Diagnostics Sales by Major Supplier
Germany, CA 125 Testing Market Diagnostics Sales by Major Supplier
Germany, CEA Testing Market Diagnostics Sales by Major Supplier
Germany, PSA Testing Market Diagnostics Sales by Major Supplier
Executive Summary Table: Italy, Total Cancer Diagnostic Testing Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Estimated Cancer Death Rates
Italy, Laboratories Performing Cancer Diagnostic Tests by Market Segment
Italy, Hospital Laboratories Performing Cancer Diagnostic Tests by Bed Size
Italy, Commercial/Private Laboratories Performing Cancer Diagnostics Tests By Annual Test Volume
Italy, Total Cancer Diagnostic Test Volume Forecasts by Market Segment
Italy, All Market Segments Major Cancer Diagnostic Test Volume Forecasts by Test
Italy, Hospital Laboratories Major Cancer Diagnostic Test Volume Forecasts
Italy, Commercial/Private Laboratories Major Cancer Diagnostic Test Volume Forecasts
Italy, Total Cancer Diagnostic Test Market Forecasts by Market Segment
Italy, All Market Segments Major Cancer Diagnostic Sales Forecasts by Test
Italy, Hospital Laboratories Major Cancer Diagnostic Forecasts by Test
Italy, Commercial/Private Laboratories Major Cancer Diagnostic Sales Forecasts by Test
Italy, ACTH Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, AFP Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Beta-2 Microglobulin Test Volume And Diagnostics Sales Forecasts by Market Segment
Italy, CA 15-3/27.29 Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, CA-19-9 Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, CA 125 Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Calcitonin Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, CEA Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Chromogranin Test Volume And Diagnostics Sales Forecasts by Market Segment
Italy, Colon Specific Antigen Test Volume And Diagnostics Sales Forecasts by Market Segment
Italy, Cytokeratins Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Estrogen Receptor Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Ferritin Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Gastrin Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, HCG Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Insulin Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Lymphocyte Subtyping Test Volume And Diagnostics Sales Forecasts by Market Segment
Italy, NSE Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Occult Blood Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Oncogenes Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecasts By Market Segment
Italy, PAP Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Parathyroid Hormone Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Progesterone Receptor Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, PAP Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, PSA Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, S-100 Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Serotonin Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Sialic Acid Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecasts By Market Segment
Italy, TDT Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Thymidine Kinase Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Thyroglobulin Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, TPA Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Total Cancer Diagnostics Sales by Major Suppliers
Italy, AFP Testing Market Diagnostics Sales by Major Supplier
Italy, CEA Testing Market Diagnostics Sales by Major Supplier
Italy, PSA Testing Market Diagnostics Sales by Major Supplier
Executive Summary Table: Spain, Total Cancer Diagnostic Testing Volume and Sales Forecasts By Market Segment
Spain, Estimated Cancer Death Rates
Spain, Laboratories Performing Cancer Diagnostic Tests by Market Segment
Spain, Hospital Laboratories Performing Cancer Diagnostic Tests by Bed Size
Spain, Commercial/Private Laboratories Performing Cancer Diagnostics Tests By Annual Test Volume
Spain, Total Cancer Diagnostic Test Volume Forecasts by Market Segment
Spain, All Market Segment Major Cancer Diagnostic Test Volume Forecasts
Spain, Hospital Laboratories Major Cancer Diagnostic Test Volume Forecasts by Test
Spain, Commercial/Private Laboratories Major Cancer Diagnostic Test Volume Forecasts
Spain, Total Cancer Diagnostic Sales Forecasts by Market Segment
Spain, All Market Segments Major Cancer Diagnostic Sales Forecasts by Test
Spain, Hospital Laboratories Major Cancer Diagnostic Sales Forecasts by Test
Spain, Commercial/Private Laboratories Major Cancer Diagnostic Sales Forecasts by Test
Spain, AFP Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain, CA 15-3 Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain, CA 19-9 Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain, CA-125 Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain, Calcitonin Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain, CEA Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain, Colon-Specific Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain, Estrogen Receptor Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain, Ferritin Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain, Gastrin Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain, HCG Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain, Insulin Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain, NSE Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain, Occult Blood Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain, Oncogenes Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain, PAP Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain, Parathyroid Hormone Test Volume And Diagnostics Sales Forecasts by Market Segment
Spain, Progesterone Receptor Test Volume and Diagnostics Sales Forecasts By Market Segment
Spain, PAP Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain, PSA Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain, S-100 Protein Test Volume And Diagnostics Sales Forecasts by Market Segment
Spain, Serotonin Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain, Sialic Acid Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecasts By Market Segment
Spain, TDT Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain, Thymidine Kinase Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain, Thyroglobulin Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain, TPA Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain, Total Cancer Diagnostics Sales By Major Suppliers
Spain, AFP Testing Market Diagnostics Sales by Major Supplier
Spain, CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
Spain, 19-9 Testing Market Diagnostics Sales by Major Supplier
Spain, CA 125 Testing Market Diagnostics Sales by Major Supplier
Spain, CEA Testing Market Diagnostics Sales by Major Supplier
Spain, PSA Testing Market Diagnostics Sales by Major Supplier
Executive Summary Table: U.K., Total Cancer Diagnostic Testing Volume and Sales Forecasts By Market Segment
U.K., Estimated Cancer Death Rates
U.K., Laboratories Performing Cancer Diagnostic Tests by Market Segment
U.K., Hospital Laboratories Performing Cancer Diagnostic Tests by Bed Size
U.K., Commercial/Private Laboratories Performing Cancer Diagnostic Tests By Annual Test Volume
U.K., Total Cancer Diagnostic Testing Volume Forecasts by Market Segment
U.K., All Market Segments Major Cancer Diagnostic Test Volume Forecasts by Test
U.K., Hospital Laboratories Major Cancer Diagnostic Test Volume Forecasts by Test
U.K., Commercial/Private Laboratories Major Cancer Diagnostic Test Volume Forecasts
U.K., Total Cancer Diagnostic Sales Forecasts by Market Segment
U.K., All Market Segments Major Cancer Diagnostic Sales Forecasts by Test
U.K., Hospital Laboratories Major Cancer Diagnostic Sales Forecasts by Test
U.K., Commercial/Private Laboratories Major Cancer Diagnostic Sales Forecasts by Test
U.K., ACTH Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., AFP Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., CA 15-3/27.29 Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., CA 19-9 Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., CA-125 Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Calcitonin Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., CEA Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Chromogranin Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Colon-Specific Antigen Test Volume And Diagnostics Sales by Market Segment
U.K., Cytokeratins Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Estrogen Receptor Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Ferritin Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Gastrin Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., HCG Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Insulin Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., NSE Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Occult Blood Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Oncogenes Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., PAP Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Parathyroid Hormone Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Progesterone Receptor Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., PAP Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., PSA Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., S-100 Protein Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Serotonin Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Sialic Acid Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., TDT Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Thymidine Kinase Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Thyroglobulin Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., TPA Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Total Cancer Diagnostics Sales and Market Shares Forecasts
U.K., CEA Testing Market Diagnostics Sales by Major Supplier
U.K., PSA Testing Market Diagnostics Sales by Major Supplier
  • PSA Test Market in US - Manufacturing and Consumption, Outlook and Forecast 2020-2026
    Published: 28-May-2020        Price: US 2700 Onwards        Pages: 101
    Prostate-specific antigen (PSA), also known as gamma-seminoprotein or kallikrein-3 (KLK3), is a glycoprotein enzyme encoded in humans by the KLK3 gene. The PSA test measures the level of PSA in a man's blood. For this test, a blood sample is sent to a laboratory for analysis. The results are usually reported as nanograms of PSA per milliliter (ng/mL) of blood. This report contains market size and forecasts of PSA Test in US, including the following market informatio......
  • Global Checkpoint Inhibitors for Treating Cancer Market Research Report 2020 (Covid-19 Version)
    Published: 27-May-2020        Price: US 3500 Onwards        Pages: 120
    Summary Checkpoint inhibitors for treating cancer is a type of drug that blocks certain proteins made by some types of immune system cells, such as T cells, and some cancer cells. These proteins help keep immune responses in check and can keep T cells from killing cancer cells. When these proteins are blocked, the "brakes" on the immune system are released and T cells are able to kill cancer cells better. Examples of checkpoint proteins found on T cells or cancer cells include PD-......
  • 2015-2027 Global Psa Test Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region
    Published: 26-May-2020        Price: US 2960 Onwards        Pages: 137
    The worldwide market for Psa Test is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2027, from X.X million US$ in 2020. The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, ......
  • COVID-19 Impact on Circulating Tumor Cell (CTC) Diagnostics Market, Global Research Reports 2020-2021
    Published: 25-May-2020        Price: US 3250 Onwards        Pages: 101
    This report covers market size and forecasts of Circulating Tumor Cell (CTC) Diagnostics, including the following market information: Global Circulating Tumor Cell (CTC) Diagnostics Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) Global Circulating Tumor Cell (CTC) Diagnostics Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) Global Circulating Tumor Cell (CTC) Diagnostics Market S......
  • 2015-2027 Global Checkpoint Inhibitors For Treating Cancer Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region
    Published: 19-May-2020        Price: US 2960 Onwards        Pages: 136
    The worldwide market for Checkpoint Inhibitors For Treating Cancer is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2027, from X.X million US$ in 2020. The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report......
  • 2015-2027 Global Circulating Tumor Cells (Ctcs) Detector Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region
    Published: 19-May-2020        Price: US 2960 Onwards        Pages: 102
    The worldwide market for Circulating Tumor Cells (Ctcs) Detector is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2027, from X.X million US$ in 2020. The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report f......
  • 2015-2027 Global Cancer Screening Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region
    Published: 19-May-2020        Price: US 2960 Onwards        Pages: 123
    The worldwide market for Cancer Screening is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2027, from X.X million US$ in 2020. The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving f......
  • Covid-19 Impact on Cancer Diagnostics Market, Global Research Reports 2020-2021
    Published: 19-May-2020        Price: US 3250 Onwards        Pages: 93
    This report covers market size and forecasts of Cancer Diagnostics, including the following market information: - Global Cancer Diagnostics Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) - Global Cancer Diagnostics Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) - Global Cancer Diagnostics Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) - Global Cancer Diagnost......
  • Global HPV Testing Market Research Report 2020 (Covid-19 Version)
    Published: 17-May-2020        Price: US 3500 Onwards        Pages: 119
    Summary The human papillomavirus (HPV) test detects the presence of human papillomavirus, a virus that can lead to the development of genital warts, abnormal cervical cells or cervical cancer. The HPV testing is further classified into three sub-segments, namely, follow-up testing, co-testing, HPV primary testing. Market Segment as follows: By Region - Asia-Pacific - North America - Europe - South America - Middle East & Afr......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs